Aromatase - A brief overview

Annual Review of Physiology

Volumn 64, Issue , 2002, Pages 93-127

  Simpson, Evan R ^a   Clyne, Colin ^a   Rubin, Gary ^a   Wah, Chin Boon ^a   Robertson, Kirsten ^a   Britt, Kara ^a   Speed, Caroline ^a   Jones, Margaret ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cancer; Estrogen biosynthesis; Extragonadal synthesis; Gene; New therapeutic concepts; Tissue specific expression

Indexed keywords

AROMATASE;

ADIPOSE TISSUE; BONE; BONE MINERALIZATION; BRAIN; CARBOHYDRATE METABOLISM; COGNITION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HORMONE BLOOD LEVEL; HUMAN; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; SEX DIFFERENCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; AROMATASE; ESTROGENS; HUMANS; NEOPLASMS;

EID: 0036193893     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.64.081601.142703     Document Type: Review

References (144)

1. Local estrogen biosynthesis in males and females
2. The role of local estrogen biosynthesis in males and females
3. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
4. Generation and reproductive phenotypes of mice lacking estrogen receptor-β
5. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β
6. Effect of single and compound knockouts of estrogen receptor alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes
7. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene
8. Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene
9. Altered expression of fatty acid metabolizing enzymes in aromatase-deficient mice
10. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
11. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice
12. Why do the sequelae of estrogen deficiency affect women more frequently than men?
13. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
14. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
15. The involvement of human placental microsomal cytochrome P450 in aromatisation
16. arom), and their use in its purification
17. Purification to homogeneity of aromatase from human placenta
18. Purification and characterization of human placental aromatase cytochrome P450
19. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature
20. Immunoaffinity purification of aromatase cytochrome P450 from human placental microsomes, metabolic switching from aromatization to 1β and 2β-monohydroxylation, and recognition of aromatase isoenzymes
21. A peroxide model reaction for placental aromatase
22. Mechanistic studies on C19 demethylation in oestrogen biosynthesis
23. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis
24. Structural characterization of the human estrogen synthetase (aromatase) gene
25. Structural and functional characterization of human aromatase P450 gene
26. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues
27. arom: The promoter responsible for expression in adipose is different from that utilized in placenta
28. Exon-specific northern analysis and rapid amplification of cDNA ends (RACE) reveal that the proximal promoter II (PII) is responsible for aromatase cytochrome P450 (CYP19) expression in human ovary
29. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue
30. Novel exon I of the aromatase gene specific for aromatase transcripts in human brain
31. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6
32. Aromatase expression in health and disease
33. Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system
34. Aromatization and 5α-reduction in brain and non-neural tissues of a cyclostome (Petromyzan marinua)
35. Aromatization is cyclic AMP-dependent in cultured reptilian brain cells
36. Hormonal control of behaviour: Steroid action in the brain
37. Distinct cytochrome P450 aromatase isoforms in zebrafish (D. rerio) brain and ovary are differentially regulated during early development
38. Two cyp19 (P450 aromatase) genes on duplicated Zebrafish chromosomes are expressed in ovary or brain
39. Genomic organization of the bovine aromatase gene and a homologous pseudogene as revealed by DNA fiber FISH
40. Demonstration of tissue-specific promoters in nonprimate species that express aromatase P450 in placentae
41. Tissue-specific expression of the bovine aromatase-encoding gene uses multiple transcriptional start sites and alternative first exons
42. Placenta-specific transcripts of the aromatase-encoding gene include different untranslated first exons in sheep and cattle
43. Multiple isoforms of porcine aromatase are encoded by three distinct genes
44. Changes in testosterone metabolism associated with the evolution of placental and gonadal isoenzymes of porcine aromatase cytochrome P450
45. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site directed mutagenesis
46. High resolution crystal structure of cytochrome P450
47. Atomic structure of the hemoprotein domain of cytochrome P450BM3: A prototype for eukaryotic microsomal P450s
48. Crystal structure and refinement of cytochrome P450terp at 2-3 Å resolution
49. Mammalian microsomal P450 monooxygenase: Structural adaptations for membrane binding and functional diversity
50. A three-dimensional model of aromatase cytochrome P450
51. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary
52. Transcriptional regulation of the rat aromatase gene in granulosa cells and R2C cells by SF-1 and CREB
53. A cell-specific nuclear receptor is essential for adrenal and gonadal development
54. Steroidogenic factor 1, a key regulation of steroidogenic gene expression, is the mouse homolog of fushi tarazu-factor 1
55. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene
56. The 5′-flanking region of the ovarian promoter of the bovine CYP19 gene contains a deletion in a cyclic adenosine 3′,5′-monophosphate-like responsive sequence
57. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes
58. Aromatase P450 gene expression in human adipose tissue: Role of a Jak/STAT pathway in regulation of the adipose-specific promoter
59. Glucocorticoid signalling - Multiple variations of common theme
60. Comparison of aromatase cytochrome P450 mRNA levels in adipose tissue from the abdomen and buttock using competitive polymerase chain reaction amplification
61. Aromatase activity in microsomal preparations of human genital skin fibroblasts: Influence of glucocorticoids
62. Androstenedione metabolism in cultured human osteoblast-like cells
63. Aromatase in bone cells: Association with osteoporosis in postmenopausal women
64. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis
65. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients
66. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene
67. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women
68. Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age
69. Increase of plasma IL-6 concentration with age in healthy subjects
70. Altered regulation of IL-6 production with normal aging
71. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and caused delipidation of developed fat cells
72. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11
73. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
74. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: Possible implications for breast cancer therapy
75. Cellular chacterization of adipose tissue from various body sites of women
76. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast
77. Aberrant expression of aromatase in breast cancer tissues
78. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells
79. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: An epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta
80. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: Mechanism of desmoplastic reaction
81. Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor
82. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH)
83. Characterization of a novel silencer element in the human aromatase gene PII promoter
84. Characterization of a cis-acting regulatory element involved in human aromatase P450 gene expression
85. Regulation of placenta-specific expression of the aromatase cytochrome P450 gene. Involvement of the trophoblast-specific element binding protein
86. Characterization of cis-acting elements of the human aromatase P450 (CYP19) gene that mediate regulation by retinoids in human choriocarcinoma cells
87. Expression of retinoic acid receptor subtypes and cellular retinoic acid binding protein II in mRNAs during differentiation of human trophoblast cells
88. PPAR gamma is required for placental, cardiac, and adipose tissue development
89. Hypoxia prevents induction of aromatase expression in human trophoblasts: Potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2)
90. A 500-bp region, approximately 40 kb upstream of the human CYP19 (aromatase) gene, mediates placenta-specific expression in transgenic mice
91. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
92. Aromatase deficiency in the male: Effect of testosterone and estradiol treatment
93. arom gene: Impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood
94. Aromatase in bone tissue
95. Aromatase expression of human osteoblast-like cells
96. Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma
97. Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue
98. Preand postnatal ontogeny of aromatase cytochrome P450 messenger RNA expression in the male rat brain studied by in situ hybridization
99. Neuroanatomical distribution of aromatase in RNA in the rat brain: Indications of regional regulation
100. Aromatase in the central nervous system
101. Estrogen biosynthesis in THP-1 cells is regulated by promoter switching of the aromatase (CYP19) gene
102. Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in the rat brain
103. Autonomous expression of aromatase during development of mouse brain is modulated by neurotransmitters
104. Factors affecting the conversion of androstenedione to estrogens by human fetal hepatocytes in monolayer culture
105. A unique aromatase (P450arom) mRNA formed by alternative use of tissue specific exons I in human skin fibroblasts
106. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues
107. Stimulation of aromatase promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element
108. Localized expression of aromatase in human vascular tissues
109. Aromatase and sex steroid receptors in human vena cava
110. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma
111. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors as well as in normal fetal and adult gonads
112. Aromatase expression in a feminizing adrenocortical tumor
113. CYP19 (aromatase) gene expression in human malignant endometrial tumors
114. Aromatase expression in endometriosis
115. A new cause of female pseudohermaphoditism: Placental aromatase deficiency
116. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries
117. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)
118. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogens
119. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
120. Oestrogen at the neonatal stage is critical for reproductive ability of male mice as revealed by supplementation with 17β-oestradiol to aromatase gene (Cyp19) knockout mice
121. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp19) gene. 1999
122. Characterization of the fertility of the male aromatase knockout (ArKO) mouse
123. Targeted disruption of the oestrogen receptor gene in male mice causes alteration of spermatogenesis and infertility
124. Germ cells of the mouse testis express P450 aromatase
125. Expression of immunolocalization of functional cytochrome P450 aromatase in mature rat testicular cells
126. Cellular localisation of rat testicular aromatase activity during development
127. P450 aromatase messenger ribonucleic acid expression in male rat germ cells: Detection by reverse transcription-polymerase chain reaction amplification
128. Another role highlighted for estrogens in the male: Sexual behaviour
129. Abolition of male sexual behaviours in mice lacking estrogen receptors α and β (αβERKO)
130. Elevated androgens and prolactin in aromatase deficient mice (ArKO) cause enlargement but not malignancy of the prostate gland
131. A role for estrogen receptor β in the regulation of growth of the ventral prostate
132. An age-related ovarian phenotype in mice with targeted disruption of the Cyp19 (aromatase) gene
133. The obese phenotype of the ArKO mouse
134. Effects of recombinant leptin therapy in a child with cogenital leptin deficiency
135. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice
136. Bone has a sexually dimorphic response to aromatase deficiency
137. The formation of estrogens by central neuroendocrine tissues
138. Role of extraglandular estrogen in human endocrinology
139. Epidemiology of spinal osteoporosis
140. Dual effects of weight and weight gain on breast cancer risk
141. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age
142. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging
143. Expression of types 1, 2 and 3 β-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women
144. Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients